Skip to main content

Table 2 SNPs and Indels identified in antibiotic resistance-associated regions in M. tuberculosis isolates

From: Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates

 

Mutations in target gene or intergenic regions (corresponding drugs)a

 

Isolates

Rv1483( mabA)b(INH)

Rv1484 ( inhA) (INH)

Rv1592c (INH)

Rv1908c ( katG) (INH)

Rv2247 ( accD6) (INH)

Rv2428 ( ahpC) (INH)

Rv2846c ( efpA) (INH)

Rv0667 ( rpoB)c(RMP)

Rv0682 ( rpsL) (STR)

Mtb562

None

None

T70(del),E321e,f,I322Vf,g

None

None

None

None

A1075e,f

None

Mtb526

None

None

T70(del),E321e,f,I322Vf,g

S315Td,g,R463Lg

D200e,f,D229Gg

S40Nf,g

None

L511Pd,g,A1075e,f

K43Rd,g,K121e,f

Mtb194

None

None

T70(del),E321e,f,I322Vf,g

R463Lg

D200e,f,D229Gg

None

None

A1075e,f

K121e,f

Mtb293

None

None

T70(del),E321e,f,I322Vf,g

C171Gf,g,R463Lg

D200e,f,D229Gg

None

None

A1075e,f

K121e,

Mtb940

None

None

T70(del),E321e,f,I322Vf,g

R463Lg

D200e,f,D229Gg

None

None

A1075e,f

K121e,f

Mtb984

None

G3 e,f

T70(del),E321e,f,I322Vf,g

S315Td,g,R463Lg

D200e,f,D229Gg

None

F128e,f

L511Pd,g,S512Gg,D516Gg,A1075e,f

K43Rd,g,K121e,f

Mtb43

T-8Cd

G3 e,f

T70(del),E321e,f,I322Vf,g

S315Td,g,R463Lg

D200e,f,D229Gg

None

None

S531Ld,g

K43Rd,g,K121e,f

  1. a“R”, resistance of isolates to the corresponding anti-TB drug; “S”, sensitivity of isolates to the corresponding anti-TB drug; “del”, deletion; INH, isoniazid; RMP, rifampicin; STR, streptomycin; EMB, ethambutol; PZA, pyrazinamide; OFX, ofloxacin; LVX, levofloxacin; KAN, kanamycin; CAP, capreomycin; AMK, amikacin; ETH, ethionamide.
  2. bintergenic regions.
  3. cnucleotide mutational position is relative to Mycobacterium tuberculosis H37Rv rpoB, and amino acid position is relative to Escherichia coli numbering.
  4. ddrug resistance-asssociated mutations with high confidence.
  5. esynonymous.
  6. fnewly identified mutations.
  7. gnon-synonymous.